BioHarvest Sciences (8MV0) Stock Overview
Operates as a biotechnology company in Israel and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
8MV0 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BioHarvest Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.02 |
| 52 Week High | US$10.80 |
| 52 Week Low | US$4.02 |
| Beta | 1.18 |
| 1 Month Change | -6.07% |
| 3 Month Change | -57.46% |
| 1 Year Change | -24.86% |
| 3 Year Change | -39.87% |
| 5 Year Change | -64.77% |
| Change since IPO | 20.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8MV0 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -3.4% | -1.2% | -3.0% |
| 1Y | -24.9% | 0.9% | 10.0% |
Return vs Industry: 8MV0 underperformed the German Personal Products industry which returned 0.4% over the past year.
Return vs Market: 8MV0 underperformed the German Market which returned 11.4% over the past year.
Price Volatility
| 8MV0 volatility | |
|---|---|
| 8MV0 Average Weekly Movement | 13.1% |
| Personal Products Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 13.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 8MV0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8MV0's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ilan Sobel | www.bioharvest.com |
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
BioHarvest Sciences Inc. Fundamentals Summary
| 8MV0 fundamental statistics | |
|---|---|
| Market cap | €94.35m |
| Earnings (TTM) | -€10.14m |
| Revenue (TTM) | €27.92m |
Is 8MV0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8MV0 income statement (TTM) | |
|---|---|
| Revenue | US$32.72m |
| Cost of Revenue | US$13.35m |
| Gross Profit | US$19.37m |
| Other Expenses | US$31.26m |
| Earnings | -US$11.89m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.52 |
| Gross Margin | 59.21% |
| Net Profit Margin | -36.33% |
| Debt/Equity Ratio | 78.1% |
How did 8MV0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/20 09:09 |
| End of Day Share Price | 2026/01/20 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioHarvest Sciences Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Amit Dayal | H.C. Wainwright & Co. |
| Anthony Vendetti | Maxim Group |